EVERSANA’s president discusses the evolving role of the Asembia conference, emerging commercialization trends, and what’s top of mind for pharma leaders this year.
Gregory Skalicky
Advertisement
Gregory Skalicky is president of EVERSANA.
Articles by Gregory Skalicky
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Top Drugs at Risk of Supply Shortages: Report
2
Amazon One Medical Launches GLP-1 Management Program
3
How Compounding Has Become a Permanent Bridge for Healthcare Access: Q&A with Dr. Nicole Snow
4
Pharmaceutical Executive Daily: Idvynso Receives FDA Approval
5